Alnylam Pharmaceuticals (ALNY) EVP reports PSU vesting and tax withholding sales
Rhea-AI Filing Summary
Alnylam Pharmaceuticals executive Pushkal Garg, EVP Chief R&D, reported equity award vesting and related tax sales. On January 11, 2026, he received 3,800 shares of common stock upon vesting of 40% of a performance-based stock unit granted on March 1, 2024. The award vested after Alnylam publicly reported $2.5 billion in annual net product revenue under GAAP, as determined by the board’s People, Culture and Compensation Committee.
On January 12, 2026, multiple small blocks of common stock were automatically sold by the company on his behalf to cover minimum statutory tax withholding obligations tied to this award. Following these transactions, Garg directly held 22,511 common shares, plus 431 shares held indirectly by a managed account and 250 shares held in a trust where his spouse is co‑trustee; he disclaims beneficial ownership of the trust shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 39 | $353.95 | $14K |
| Sale | Common Stock | 42 | $355.16 | $15K |
| Sale | Common Stock | 41 | $356.09 | $15K |
| Sale | Common Stock | 96 | $357.17 | $34K |
| Sale | Common Stock | 123 | $358.18 | $44K |
| Sale | Common Stock | 85 | $359.14 | $31K |
| Sale | Common Stock | 155 | $360.22 | $56K |
| Sale | Common Stock | 98 | $361.45 | $35K |
| Sale | Common Stock | 73 | $362.38 | $26K |
| Sale | Common Stock | 47 | $363.55 | $17K |
| Sale | Common Stock | 199 | $364.83 | $73K |
| Sale | Common Stock | 220 | $365.56 | $80K |
| Sale | Common Stock | 50 | $366.41 | $18K |
| Sale | Common Stock | 41 | $367.40 | $15K |
| Sale | Common Stock | 92 | $368.62 | $34K |
| Sale | Common Stock | 40 | $369.48 | $15K |
| Sale | Common Stock | 18 | $370.87 | $7K |
| Sale | Common Stock | 3 | $372.46 | $1K |
| Sale | Common Stock | 14 | $374.44 | $5K |
| Sale | Common Stock | 19 | $375.65 | $7K |
| Sale | Common Stock | 15 | $377.82 | $6K |
| Grant/Award | Common Stock | 3,800 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- On March 1, 2024, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of forty (40) percent of the shares subject to the PSU based on the issuer publicly reporting $2.5 billion in annual net product revenue in accordance with GAAP, as determined by the People, Culture and Compensation Committee of the Issuer Board of Directors on January 11, 2026. Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $353.53 to $354.41. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $354.54 to $355.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.62 to $356.61. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.63 to $357.63. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $357.68 to $358.68. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $358.69 to $359.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $359.79 to $360.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $360.90 to $361.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $361.93 to $362.92. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $362.99 to $363.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $364.00 to $365.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $365.01 to $366.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $366.03 to $366.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $367.04 to $368.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $368.09 to $369.08. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $369.13 to $369.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $370.43 to $371.23. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $372.35 to $372.50. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $374.08 to $374.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program. Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
FAQ
What insider activity did ALNY executive Pushkal Garg report on this Form 4?
The filing shows that EVP Chief R&D Pushkal Garg received 3,800 shares of Alnylam common stock from a performance-based stock unit vesting and that multiple small blocks of shares were automatically sold to cover related tax withholding obligations.
What indirect Alnylam (ALNY) holdings are reported for Pushkal Garg?
The filing lists 431 shares held indirectly by a managed account and 250 shares held in a trust where his spouse is co‑trustee. The reporting person disclaims beneficial ownership of the trust shares.
What performance conditions were tied to Pushkal Garg’s Alnylam PSU award?
The performance-based stock unit granted on March 1, 2024 vests on three specified performance measures. The 40% portion reported here vested based on Alnylam publicly reporting $2.5 billion in annual net product revenue in accordance with GAAP.